Biosplice Therapeutics
Medical research and development for tissue-level regeneration.
Launch date
Employees
Market cap
-
Enterprise valuation
$11.6b (Public information from Apr 2021)
San Diego California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
$220m | Series A | ||
* | $438m Valuation: $11.6b | Series B | |
N/A | Series C | ||
$120m Valuation: $11.6b | Late VC | ||
* | N/A | Grant | |
| Total Funding | $778m | ||
Related Content
Recent News about Biosplice Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.